To avoid these problems, researchers have developed diverse analytical strategies, encompassing label-free electrochemical methods and surface plasmon resonance sensing platforms, to achieve sensitive detection of ovarian cancer biomarkers CA125 and HE4, both individually and simultaneously [13,14,15,16]. The gene discussed is WFDC2; the disease is ovarian cancer.